WELTON MARK

IMAX President Welton Mark sells 25,000 shares at $39.28; stock near 52-week high of $39.04 after +20.2% 90-day surge

Welton Mark, President of IMAX Global Theatres, sold 25,000 shares (a 16.3% reduction of prior holdings) at $39.28 on 2025-12-15, with the stock currently trading at $39.04—at its 52-week high—following a 90-day gain of +20.2%. This sale occurs as IMAX's valuation has expanded significantly: the P/E of 52.76 is notably elevated, and annual revenue has contracted by -6.0% year-over-year even as recent quarterly revenue stands at $106.7M and net income at $20.7M. Mark's cross-ticker track record across 2 prior sells shows a 100.00% well-timed rate at the 90-day mark (sales preceded declines), and his prior sale at IMAX on 2025-11-10 has posted +8.2% returns over 30 days—suggesting the stock may still be climbing post-transaction. The timing context—selling into a near-52-week-high after strong recent appreciation and amid elevated valuation multiples relative to revenue contraction—distinguishes this transaction from routine portfolio activity.

President Mark Welton sold 49.5K IMAX shares at $35.23; holdings drop 24.4% to 153.3K post-transaction

Mark Welton, President of IMAX Global Theatres, sold 49,504 shares at $35.23 on 2025-11-10 for $1,743,926.91, reducing his shareholding by 24.4% to 153,323 shares. The sale occurs near IMAX's 52-week high of $35.66, with the stock up 14.3% over 30 days and 39.2% over 90 days—a period of significant appreciation. Notably, a prior sale by this insider on 2024-12-09 registered -7.6% return over 30 days and -1.0% over 90 days, establishing a pattern of well-timed selling at IMAX (100% of his 1 prior IMAX sale was well-timed at the 90-day mark). However, the FLAG note indicates this filing contains a derivative-conversion transaction; the insider's full position may extend beyond the Table I shares shown, with derivative holdings not yet populated in the database, so the 24.4% reduction reflects only the explicitly traded open-market batch, not his total economic exposure.

IMAX President Mark Welton sold 39,432 shares at $25.51 on 2024-12-09; retains 111,315 shares post-sale.

Mark Welton, President of IMAX Theatres, sold 39,432 shares at $25.51 on 2024-12-09, reducing his holdings by 26.2% to 111,315 shares. The sale occurred near the 52-week high (current price $25.55 is 4.4% below the $26.73 peak), during a period of strong stock momentum—90-day change +21.6% and 30-day change +4.9%. The company's fundamentals show robust performance with annual revenue growth of +24.6% and recent quarterly net income of $13.9M against $91.5M in revenue, though the P/E of 58.07 reflects elevated valuation expectations. The insider's continuing stake of 111,315 shares signals retained alignment with the company. However, the filing contains a derivative-conversion transaction (Form 4 Table II), meaning the full scope of Welton's equity position is not captured in the Form 4 Table I shares shown here; investors should review the complete filing for the complete position accounting.